Biotechs Pressured Following Clinton Tweet (IBB)

Go back to Biotechs Pressured Following Clinton Tweet (IBB)

Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says

September 21, 2015 1:57 PM UTC

BMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More

UPDATE: Biotech Bounces Off Lows (IBB)

September 21, 2015 1:19 PM UTC

(Updated - September 21, 2015 1:29 PM EDT)

Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More

Cowen Remains Bullish on Gilead Sciences (GILD) Following Data Release

September 21, 2015 1:13 PM UTC

Cowen reiterated an Outperform rating and $125.00 price target on Gilead Sciences (NASDAQ: GILD) following the release top-line data from the Ph. III ASTRAL trials of SOF+VEL.

Analyst Phil Nadeau commented, "GILD released top-line data from the Ph. III ASTRAL trials of... More